Johnson & Johnson Agrees to End Opioid Business With $230 Million Settlement

Johnson & Johnson has agreed to a $230 million settlement with New York state to prevent the promotion and sale of opioids within the United States. Over the last few decades, the opioid epidemic has killed nearly 500,000 people in the country, prompting years of lawsuits against major pharmaceutical companies.  The agreement includes the resolution … Continue reading Johnson & Johnson Agrees to End Opioid Business With $230 Million Settlement